The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study
Open accessAbstract
OBJECTIVE: To determine the efficacy of an angiotensin converting enzyme inhibitor in the prophylaxis of migraine. DESIGN: Double blind, placebo controlled, crossover study. SETTING: Neurological outpatient clinic. PARTICIPANTS: Sixty patients aged 19-59 years with migraine with two to six episodes a month. INTERVENTIONS: Treatment period of 12 weeks with one 10 mg lisinopril tablet once daily for one week then two 10 mg lisinopril tablets once daily for 11 weeks, followed by a two week wash out period. Second treatment period of one placebo tablet once daily for one week and then two placebo tablets for 11 weeks. Thirty participants followed this schedule, and 30 received placebo followed by lisinopril. MAIN OUTCOME MEASURES: Primary end points: number of hours with headache, number of days with headache, number of days with migraine. Secondary end points: headache severity index, use of drugs for symptomatic relief, quality of life and number of days taken as sick leave, acceptability of treatment. RESULTS: In the 47 participants with complete data, hours with headache, days with headache, days with migraine, and headache severity index were significantly reduced by 20% (95% confidence interval 5% to 36%), 17% (5% to 30%), 21% (9% to 34%), and 20% (3% to 37%), respectively, with lisinopril compared with placebo. Days with migraine were reduced by at least 50% in 14 participants for active treatment versus placebo and 17 patients for active treatment versus run-in period. Days with migraine were fewer by at least 50% in 14 participants for active treatment versus placebo. Intention to treat analysis of data from 55 patients supported the differences in favour of lisinopril for the primary end points. CONCLUSION: The angiotensin converting enzyme inhibitor, lisinopril, has a clinically important prophylactic effect in migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,797
Introduction to sample size determination and power analysis for clinical trials
Lachin, J. M. (1981) · Controlled Clinical Trials · doi:10.1016/0197-2456(81)90001-5 · Cited by 1,012
The SF-36 Health Survey: Development and Use in Mental Health Research and the IQOLA Project
Ware, Jr., & Gandek, B. (1994) · International Journal of Mental Health · doi:10.1080/00207411.1994.11449283 · Cited by 597
Guidelines for Controlled Trials of Drugs in Migraine. First Edition
(1991) · Cephalalgia · doi:10.1046/j.1468-2982.1991.1101001.x · Cited by 189
Propranolol in the Management of Recurrent Migraine: A Meta‐analytic Review
Holroyd, K. A., Penzien, D. B., & Cordingley, G. E. (1991) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1991.hed3105333.x · Cited by 171
The Broad Substrate Specificity of Human Angiotensin I Converting Enzyme
Skidgel, R. A., & Erdös, E. G. (1987) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968709164184 · Cited by 161
Paterna, S., Pasquale, P. D., D’Angelo, A., Seidita, G., Tuttolomondo, A., Cardinale, A., Maniscalchi, T., Follone, G., Giubilato, A., Tarantello, M., et al. (2000) · European Neurology · doi:10.1159/000008151 · Cited by 132
Sexual function in hypertensive males treated with lisinopril or atenololA cross-over study
Fogari, R., Zoppi, A., Corradi, L., Mugellini, A., Poletti, L., & Lusardi, P. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00139-3 · Cited by 113
Goa, K. L., Balfour, J. A. B., & Zuanetti, G. (1996) · Drugs · doi:10.2165/00003495-199652040-00011 · Cited by 24
Cited by
Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775
“24%; table 6) and they are no less effective after myocardial infarction. All classes of drug prevent headaches and migraine,”
BackgroundSilberstein, S. D., Holland, S., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535d20 · Cited by 897
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Tronvik, E., Stovner, L. J., Helde, G., Sand, T., & Bovim, G. (2003) · JAMA · doi:10.1001/jama.289.1.65 · Cited by 355
Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention
Lipton, R. B., & Silberstein, S. D. (2015) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12505_2 · Cited by 322
Metadata
- Authors
- Schrader, H.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2001-01-06
- Volume
- 322
- Issue
- 7277
- Pages
- 19-19
- ISSN
- 0959-8138 (ISSN-L)
- OpenAlex
- W1999768227
- Cited by
- 288
- References
- 13
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.